Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 15,643 |
|
|||||
| News | - | ||||||
| Day High | 4.8275 | Low High |
|||||
| Day Low | 4.636 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| enVVeno Medical Corporation | NVNO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.10 | -2.11% | 4.65 | 12:08:23 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.70 | 4.636 | 4.8275 | 4.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 124 | 15,643 | $ 4.71 | $ 73,716 | - | 2.51 - 6.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:11:37 | 27 | $ 4.68 | USD |
enVVeno Medical Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 138.23M | 13.32M | - | 0 | -23.52M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
enVVeno Medical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVNO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.9461 | 5.01 | 4.6201 | 4.77 | 44,424 | -0.2961 | -5.99% |
| 1 Month | 5.11 | 5.2199 | 4.6201 | 4.91 | 42,039 | -0.46 | -9.00% |
| 3 Months | 6.20 | 6.255 | 4.57 | 5.20 | 57,404 | -1.55 | -25.00% |
| 6 Months | 3.66 | 6.97 | 3.50 | 5.29 | 97,586 | 0.99 | 27.05% |
| 1 Year | 2.99 | 6.97 | 2.51 | 4.95 | 80,497 | 1.66 | 55.52% |
| 3 Years | 10.38 | 10.75 | 2.51 | 5.43 | 53,838 | -5.73 | -55.20% |
| 5 Years | 10.38 | 10.75 | 2.51 | 5.43 | 53,838 | -5.73 | -55.20% |
enVVeno Medical Description
| enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). |
